Skip to Content

Join the 'ProAir RespiClick' group to help and get support from people like you.

ProAir RespiClick News

COPD Deaths Down for Most Americans: CDC

Posted 8 Sep 2016 by Drugs.com

THURSDAY, Sept. 8, 2016 – Fewer Americans are dying from chronic obstructive pulmonary disease (COPD), but not black women and the middle-aged, a new government report shows. Between 2000 and 2014, there was a 12 percent overall drop in deaths from the progressive lung disease, according to the U.S. Centers for Disease Control and Prevention. Report co-author Hanyu Ni said the figures aren't unexpected, noting that "the declines in the COPD-related mortality are consistent with declines in the prevalence of current smoking for men and women in the United States." But, Ni added, the study only quantified death rate trends, and didn't look at the reasons behind those trends. Ni is an associate director for science with the CDC's division of vital statistics at the U.S. National Center for Health Statistics. Dr. David Mannino, who's with the University of Kentucky's College of Public ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Albuterol, Spiriva, Chronic Obstructive Pulmonary Disease, Maintenance, Ventolin, Fluticasone, Ribavirin, Qvar, Flovent, Budesonide, Epinephrine, Xopenex, Ipratropium, Entocort, Tobramycin, ProAir HFA, Mometasone, EpiPen, Atrovent, Proventil

Health Tip: Create an Asthma Action Plan

Posted 16 May 2016 by Drugs.com

-- An asthma action plan can help people with asthma handle an attack quickly and safely. The U.S. Centers for Disease Control and Prevention recommends: Creating the action plan with your doctor's assistance. Including in your plan the asthma treatments taken daily, including the type of medications and when taken. Including a plan for long-term asthma control. Including a plan for an asthma attack. Noting when it's appropriate to visit the doctor or go to the emergency room. If the plan is for a child, giving the plan to anyone who cares for that child, including daycare providers and teachers. Read more

Related support groups: Asthma, Albuterol, Asthma - Maintenance, Ventolin, Fluticasone, Qvar, Ribavirin, Asthma - Acute, Combivent, Flovent, Budesonide, Entocort, ProAir HFA, Tobramycin, Mometasone, Proventil, Entocort EC, Acetylcysteine, Mucomyst, Beclomethasone

Many COPD Patients Have Trouble Finding Care

Posted 13 May 2016 by Drugs.com

FRIDAY, May 13, 2016 – Americans with chronic obstructive pulmonary disease face high out-of-pocket costs and other significant barriers to adequate medical care, a new report finds. "This report reveals a real patchwork of care for patients with chronic obstructive pulmonary disease," the report's lead author, Dr. Meilan Han, said in a news release from The Lancet Respiratory Medicine. The report, written by experts in the field of respiratory health, was commissioned by the journal to provide the first comprehensive look at chronic obstructive pulmonary disease (COPD) care in the United States. COPD is the third leading cause of death in the United States, Han said. And the condition disproportionately affects some of society's most vulnerable people, such as older people and those with low incomes. Many COPD patients lack access to medications and treatments that could improve their ... Read more

Related support groups: Chronic Obstructive Pulmonary Disease, Albuterol, Chronic Obstructive Pulmonary Disease, Maintenance, Ventolin, Fluticasone, Qvar, Combivent, Flovent, Budesonide, Entocort, ProAir HFA, Mometasone, Proventil, Entocort EC, Chronic Obstructive Pulmonary Disease, Acute, Beclomethasone, Pulmicort Flexhaler, Ventolin HFA, Alvesco, Asmanex Twisthaler

Teva Announces FDA Approval of ProAir RespiClick (albuterol sulfate) Inhalation Powder for Pediatric Asthma Patients Ages 4 to 11

Posted 2 May 2016 by Drugs.com

JERUSALEM--(BUSINESS WIRE)--Apr. 29, 2016-- Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved ProAir RespiClick (albuterol sulfate) Inhalation Powder for the treatment or prevention of bronchospasm in children 4 to 11 years of age with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm (EIB). ProAir RespiClick was approved by the FDA for use in patients 12 years of age and older in March 2015 and remains the only breath-activated, multi-dose, dry powder, short-acting beta-agonist (SABA) inhaler available in the U.S. “The prevalence of childhood asthma in the U.S. is high, at more than six million patients, and that number continues to rise,” said Dr. Erwin Gelfand, Chairman, Department of Pediatrics at National Jewish Health. “For this young population of as ... Read more

Related support groups: Asthma, Albuterol, Asthma - Acute, ProAir RespiClick

Ask a Question

Further Information

Related Condition Support Groups

Chronic Obstructive Pulmonary Disease, Acute, Asthma - Maintenance, Asthma - Acute, Bronchiectasis, Bronchospasm Prophylaxis, Chronic Obstructive Pulmonary Disease, Maintenance

ProAir RespiClick Patient Information at Drugs.com